Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 15, 2017 (10 years ago)

Famciclovir tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13

Affected NDC 50268-0307-13

Compare with the code on your package — it is the most precise check available.

Drug: Famciclovir

Recalling firm
AVKARE Inc.
NDC code
50268-307-13
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0610-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Famciclovir recalls

See all
Class III · Low risk

Famciclovir Tablets

Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.

Ongoing Particulate / foreign matter Macleods Pharmaceuticals Ltd NDC 33342-026-07 D-0509-2025
Class II · Moderate risk

Famciclovir Tablets

Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.

Terminated Temperature excursion Hetero Labs Limited Unit V NDC 31722-708-30 D-0415-2018
Class II · Moderate risk

Famciclovir active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-671-2015
Class II · Moderate risk

Famciclovir

Labeling: Label Mixup: FAMCICLOVIR, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs: TOLTERODINE TARTRATE ER, Capsule, 4 mg, NDC 00009519101, Pedigree: AD49448_1, EXP: 5/17/2014; THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedigree: AD54559_1, EXP: 5/20/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-851-2014

Other recalls by AVKARE Inc.

All 2017 recalls
Class II · Moderate risk

Amantadine HCl

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Ongoing Dissolution failure AvKARE NDC 50268-069-15 D-0341-2026